Different Skin Prick Test Sensitization Patterns Do Not Influence the Response to Omalizumab in Severe Asthma

J Investig Allergol Clin Immunol. 2017;27(6):388-391. doi: 10.18176/jiaci.0196.

¹ Pneumology Department, Misericordia Hospital, Grosseto, Italy.
² Institute of Clinical Phisiology, CNR, Pisa, Italy.
³ Pneumology Department, S.Corona Hospital, Pietra Ligure, Italy.
⁴ Otorhinolaryngology Clinic, Policlinico Umberto I, "Sapienza" University, Rome, Italy.
⁵ Cardio Thoracic and Vascular Department, Pathophysiology Unit, University of Pisa, Pisa, Italy.
⁶ DIMPEFINU, Unit of Pneumology and Medicine, University of Palermo, Palermo, Italy.
⁷ Immunoallergology Unit, Department of Medicine and Geriatric, AOU Careggi, Florence, Italy.
⁸ Division of Pneumology, Department of Clinical and Molecular Medicine, Sapienza University of Rome, AOU Sant´Andrea, Rome, Italy.
⁹ Cardiology Department, Misericordia Hospital, Grosseto, Italy.

No abstract available

Keywords: Effectiveness; Omalizumab; Pollen sensitized; Real-life; Severe asthma.

Publication types